Concepedia

Gary A. Ulaner

GA

Statistics

Publications

114

Citations

9K

H-Index

51

Active since

1997

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Hoag Memorial Hospital Presbyterian

University of Southern California

VA Palo Alto Health Care System

Gary A. Ulaner is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and nuclear medicine.

Publications per year

1997–2025

114

Publications

114

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 783 citations

Medicine, Cancer Biology, Oncology +14

Ado-Trastuzumab Emtansine for Patients With <i>HER2</i>-Mutant Lung Cancers: Results From a Phase II Basket Trial

Bob T. Li, Ronglai Shen, Darren J. Buonocore et al. · Journal of Clinical Oncology · 2018 · 559 citations

Medicine, Oncology, Pharmacology +17

Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.

Gary A. Ulaner, Ji‐Fan Hu, Thanh Vu et al. · PubMed · 1998 · 501 citations

Life Sciences, Developmental Biology, Molecular Biology +16

Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

Eli L. Diamond, Vivek Subbiah, A. Craig Lockhart et al. · JAMA Oncology · 2017 · 405 citations · Full text

Medicine, Oncology, Pharmacology +13

Efficacy of MEK inhibition in patients with histiocytic neoplasms

Eli L. Diamond, Benjamin H. Durham, Gary A. Ulaner et al. · Nature · 2019 · 384 citations

Medicine, Cell Biology, Oncology +10

1–5 of 114